There is a newer version of the record available.

Published March 20, 2018 | Version v1
Dataset Open

The process of HDAC11 Assay Development: time-course study follow-up

Creators

  • 1. Structural Genomics Consortium/University of Toronto

Description

A follow-up to check the increased fluorescence signals at 0 min of the HDAC11 reaction with its substrate was performed. 

Notes

The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.

Files

20march2018-HDAC11 assay deve process-time course followup.pdf

Files (122.8 kB)